Integrated RFID and Sensor Networks for Health Care

Moh, Melody; Moh, Teng-Sheng; Walker, Zachary

doi:10.1201/9781420077780.ch20

Cited by 4 publications

(3 citation statements)

References 16 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…In this study, total of 63/103 (61.2%) patients had good respond to neoadjuvant chemotherapy. 3,4 Study by He et al (2018) stated that as many as 93.4% of patients with squamous cell carcinoma histopathology type gave a good response to neoadjuvant chemotherapy and only 75% adenocarcinoma patients respond well to chemotherapy neoadjuvant. 5 Modares M. et al (2004) conducted a study to 30 cervical cancer patients that treated with neoadjuvant chemotherapy, about 27/30 (90%) patients had squamous cell carcinoma type.…”

Section: Relationship Between Histopathology Type and Neoadjuvant Chementioning

confidence: 99%

Relationships Between Histopathology Type and Neoadjuvant Chemotherapy Response in IB2 and IIA2 Cervical Cancer

Muhammad

2020

AOJ

View full text Add to dashboard Cite

AbstrctBackground: Cervical cancer was the fourth common cancer in women in the world and the second most in Indonesia. Chemotherapy has been evaluated as a therapy strategies to treat stage IB2 and IIA2 cervical cancer. Neoadjuvant chemotherapy was still being a controversy for the chemotherapy resistance patient. This would delay the provision of definitive therapy. A marker is needed to identify patient which more relatively resistant to chemotherapy. Squamous Cell Carcinoma (SCC) type was known be have better response to neoadjuvant chemotherapy than non-Squamous Cell Carcinoma (nSCC) type, but there no studies at Dr.M.Djamil General Hospital yet on this matter before. Objective: To obtain the relationship between histopathology type and neoadjuvant chemotherapy response on cervical stage IB2 and IIA2 cervical canser. Method: This cohort analytic study conducted at Dr.M.Djamil Padang Hospital which obtained 35 samples of stage IB2 and IIA2 cervical cancer patients whom treated with neoadjuvant chemotherapy. Sampling was done by consecutive sampling technique. Results of histopathology and results of ultrasound examinations before and after given neoadjuvant chemotherapy were included to data. Data analysis used Chi-Square test. Results: CR + PR in the SCC and NSCC group were 32% and 50%, while SD + PD was 68% in SCC group and 50% in NSCC group. Conclusion: There was no significant relationship between histopathological type and neoadjuvant chemotherapy response to stage IB2 and IIA2 cervical cancer (p = 0.44). AbstrakLatar belakang: Kanker serviks menempati urutan keempat di seluruh dunia dan urutan kedua di Indonesia yang paling umum terjadi pada wanita. Kemoterapi telah dievaluasi sebagai salah satu strategi pengobatan kanker serviks stadium IB2 dan IIA2. Namun penggunaan kemoterapi neoadjuvant masih kontroversi pada pasien yang resisten dengan kemoterapi. Hal ini akan menunda pemberian terapi Volume 4, Nomor definitif, sehingga sangat penting untuk menemukan penanda yang dapat mengidentifikasi pasien mana yang relatif lebih resisten terhadap kemoterapi. Tipe squamous cell carcinoma (SCC) diketahui memiliki respon kemoterapi neoadjuvant yang lebih baik dibandingkan dengan non-squamous cell carcinoma (nSCC) namun belum ada penelitian yang dilakukan di RSUP M Djamil Padang mengenai hal ini sebelumnya. Tujuan: Untuk melihat Hubungan Tipe Histopatologi Dengan Respon Kemoterapi Neoadjuvant Pada Kanker Serviks Stadium IB2 Dan IIA2. Metode: Penelitian ini merupakan studi analitik cohort yang dilakukan di RSUP Dr. M. Djamil Padang pada 35 sampel pasien kanker serviks stadium IB2 dan IIA2 yang diberikan kemoterapi neoadjuvant. Pengambilan sampel dilakukan dengan teknik consecutive sampling. Data meliputi hasil gambaran histopatologi serta hasil pemeriksaan ultrasonografi sebelum dan sesudah diberikan kemoterapi neoadjuvant. Analisis data mengunakan uji Chi-Square. Hasil: CR+PR pada kelompok SCC adalah sebesar 32% dan NSCC adalah 50%, sedangkan SD+PD adalah sebesar 68 % pada kelompok SCC dan 50% pada kelompok NSCC. K...

show abstract

Section: Relationship Between Histopathology Type and Neoadjuvant Chementioning

confidence: 99%

Relationships Between Histopathology Type and Neoadjuvant Chemotherapy Response in IB2 and IIA2 Cervical Cancer

Muhammad

2020

AOJ

View full text Add to dashboard Cite

show abstract

“…The major factors that hinder the effective implementation of malaria in pregnancy control measures include low utilization of antenatal care (ANC) services leading to sub-optimal uptake of IPTp, improper case management leading to malaria rebound or even drug resistance, high transmission intensity, inadequate epidemic preparedness, and a limited epidemiological and surveillance data to inform decision making. In 2020, Uganda updated its guidelines for managing malaria in pregnancy following upsurges in 2018 and 2019 [28]. The new guidelines necessitate that all pregnant women attending routine ANC receive a test for malaria.…”

Section: Introductionmentioning

confidence: 99%

High prevalence of malaria in pregnancy among women attending antenatal care at a large referral hospital in northwestern Uganda: A cross-sectional study

et al. 2023

View full text Add to dashboard Cite

Background Malaria in pregnancy contributes to substantial morbidity and mortality among women in Uganda. However, there is limited information on the prevalence and factors associated with malaria in pregnancy among women in Arua district, northwestern Uganda. We, therefore, assessed the prevalence and factors associated with malaria in pregnancy among women attending routine antenatal care (ANC) clinics at Arua regional referral hospital in north-western Uganda. Methods We conducted an analytic cross-sectional study between October and December 2021. We used a paper-based structured questionnaire to collect data on maternal socio-demographic and obstetric factors and malaria preventive measures. Malaria in pregnancy was defined as a positive rapid malarial antigen test during ANC visits. We performed a modified Poisson regression analysis with robust standard errors to determine factors independently associated with malaria in pregnancy, reported as adjusted prevalence ratios (aPR) and 95% confidence intervals (CI). Results We studied 238 pregnant women with a mean age of 25.32±5.79 years that attended the ANC clinic, all without symptomatic malaria. Of the participants, 173 (72.7%) were in their second or third trimester, 117 (49.2%) were first or second-time pregnant women, and 212 (89.1%) reported sleeping under insecticide-treated bednets (ITNs) every day. The prevalence of malaria in pregnancy was 26.1% (62/238) by rapid diagnostic testing (RDT), with the independently associated factors being daily use of insecticide-treated bednets (aPR 0.41, 95% CI 0.28, 0.62), first ANC visit after 12 weeks of gestation (aPR1.78, 95% CI 1.05, 3.03), and being in the second or third trimester (aPR 0.45, 95% CI 0.26, 0.76). Conclusion The prevalence of malaria in pregnancy among women attending ANC in this setting is high. We recommend the provision of insecticide-treated bednets to all pregnant women and early ANC attendance to enable access to malaria preventive therapy and related interventions.

show abstract

“…National EPI programmes frequently utilize routine immunization data from national health information systems to evaluate coverage at both national and subnational levels. The standard approach to computing annual vaccine coverage for various antigens is by calculating the proportion of children who receive a vaccine relative to the total projected population of children under 1 year (denominator) [10][11][12][13]. However, the effectiveness of this method is hindered by inaccurate estimates of the target denominator population size and a lack of accounting for migrations and health facility catchments [12,14].…”

Section: Introductionmentioning

confidence: 99%

Malaria vaccine coverage estimation using age-eligible populations and service user denominators in Kenya

Moturi,

Jalang’o,

Cherono

et al. 2023

Malar J

View full text Add to dashboard Cite

Background The World Health Organization approved the RTS,S/AS01 malaria vaccine for wider rollout, and Kenya participated in a phased pilot implementation from 2019 to understand its impact under routine conditions. Vaccine delivery requires coverage measures at national and sub-national levels to evaluate progress over time. This study aimed to estimate the coverage of the RTS,S/AS01 vaccine during the first 36 months of the Kenyan pilot implementation. Methods Monthly dose-specific immunization data for 23 sub-counties were obtained from routine health information systems at the facility level for 2019–2022. Coverage of each RTS,S/AS01 dose was determined using reported doses as a numerator and service-based (Penta 1 and Measles) or population (projected infant populations from WorldPop) as denominators. Descriptive statistics of vaccine delivery, dropout rates and coverage estimates were computed across the 36-month implementation period. Results Over 36 months, 818,648 RTSS/AS01 doses were administered. Facilities managed by the Ministry of Health and faith-based organizations accounted for over 88% of all vaccines delivered. Overall, service-based malaria vaccine coverage was 96%, 87%, 78%, and 39% for doses 1–4 respectively. Using a population-derived denominator for age-eligible children, vaccine coverage was 78%, 68%, 57%, and 24% for doses 1–4, respectively. Of the children that received measles dose 1 vaccines delivered at 9 months (coverage: 95%), 82% received RTSS/AS01 dose 3, only 66% of children who received measles dose 2 at 18 months (coverage: 59%) also received dose 4. Conclusion The implementation programme successfully maintained high levels of coverage for the first three doses of RTSS/AS01 among children defined as EPI service users up to 9 months of age but had much lower coverage within the community with up to 1 in 5 children not receiving the vaccine. Consistent with vaccines delivered over the age of 1 year, coverage of the fourth malaria dose was low. Vaccine uptake, service access and dropout rates for malaria vaccines require constant monitoring and intervention to ensure maximum protection is conferred.

show abstract

Integrated RFID and Sensor Networks for Health Care

Cited by 4 publications

References 16 publications

Relationships Between Histopathology Type and Neoadjuvant Chemotherapy Response in IB2 and IIA2 Cervical Cancer

Relationships Between Histopathology Type and Neoadjuvant Chemotherapy Response in IB2 and IIA2 Cervical Cancer

High prevalence of malaria in pregnancy among women attending antenatal care at a large referral hospital in northwestern Uganda: A cross-sectional study

Malaria vaccine coverage estimation using age-eligible populations and service user denominators in Kenya

Contact Info

Product

Resources

About